Bajaj Consumer Care Limited
NSE: BAJAJCONPersonal Care
Share price
₹506.95
+3.64% close of 9 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 9 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
65
out of 100 · worked out 9 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹6,590 Cr
P/E ratio
29.6
P/B ratio
8.8
ROCE
30.0%
ROE
24.6%
Dividend yield
0.0%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 24.9% over the past year, and 6.3% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales improved from 17.4% to 21.0% over the last four years.
Whether it grew faster than its sector
It grew 6.3% a year against a sector median of 9.9% — 3.6 percentage points slower.
Room to re-rate, or risk of de-rating
At 29.6× earnings against a market that pays 24.1× across 2199 companies we can price. Its own industry sits at 36.4×, across 5 companies. It is against its own five-year median of 18.5×, the 89th percentile of its own range.
Whether growth justifies the valuation
Priced at 3.0 times its growth rate, on earnings growth of 10%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Bajaj Consumer Care Limited — this one | 10%/yr | 29.6× | ₹3.0 |
| Godrej Consumer Products | 5%/yr | 42.3× | ₹8.5 |
| Dabur India | 4%/yr | 34.5× | ₹8.6 |
| Colgate-Palmolive India | 8%/yr | 36.4× | ₹4.6 |
| Cupid Limited | — | 358.1× | — |
| Gillette India Limited | 31%/yr | 35.1× | ₹1.1 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Personal Care), it ranks 5 of 10 on returns, 9 of 10 on growth, 8 of 10 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
A narrow advantage: it earns 30% on capital, ahead of 50% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
Yes — Over the last five years it made ₹608 crore of cash from the business, spent ₹60 crore on plant and equipment, and returned ₹815 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 90 arrived as cash. Its cash comes back more slowly than it used to: it went from being waiting 1 days for its cash to waiting 9 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
10 of 10 checks clear · 100%
Latest result
What the last results showed. Whether management kept its word is in Pro.
Results are expected soon.
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹6,590 Cr
- Prev close
- ₹506.95
- 52w High
- ₹692
- 52w Low
- ₹243
- Enterprise value
- ₹6,200 Cr
- Beta
- 0.9
- Price CAGR 1y
- 100.0%
- Price CAGR 3y
- 28.0%
- Price CAGR 5y
- 14.0%
- Price CAGR 10y
- 2.0%
Ratios
- Return on assets
- 20.1%
- PEG ratio
- 3.0
- P/E ratio
- 29.6
- P/B ratio
- 8.8
- EV / EBITDA
- 23.5
- Industry P/E
- 34.6
- ROCE
- 30.0%
- ROCE 5y average
- 23.8%
- ROE
- 24.6%
- Debt / Equity
- 0.0
- Interest coverage
- 116.5
- Dividend yield
- 0.0%
- ROE 3y average
- 20.0%
- ROE last year
- 25.0%
Annual P&L
- Annual revenue
- ₹1,165 Cr
- Annual profit
- ₹190 Cr
- Operating margin
- 19.0%
- Net profit margin
- 16.3%
- EBITDA margin
- 19.0%
- Sales growth 3y
- 6.6%
- Sales growth 5y
- 4.8%
- Profit growth 3y
- 10.0%
- Profit growth 5y
- -4.0%
- EPS
- ₹14.6
- Sales growth TTM
- 25.0%
- Profit growth TTM
- 76.0%
- Dividend payout
- 0.0%
Quarter P&L
- Sales latest quarter
- ₹342 Cr
- Profit latest quarter
- ₹71 Cr
- YoY quarterly sales growth
- 24.9%
- YoY quarterly profit growth
- 86.8%
- OPM latest quarter
- 24.4%
Balance Sheet
- Book Value
- ₹58.1
- Face Value
- ₹1.0
- Total debt
- ₹16 Cr
- Total cash
- ₹39 Cr
- Borrowings
- ₹16 Cr
- Reserves / Equity
- 57.1
Cash Flow
- Operating cash flow
- ₹197 Cr
- Free cash flow
- ₹163 Cr
- FCF yield
- 2.5%
- Net cash flow
- -₹14 Cr
Shareholding
- Promoter holding
- 43.0%
- FII holding
- 16.4%
- DII holding
- 14.9%
- Public holding
- 25.7%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Consumer | 865.55 | 42.7 | 88,623 | 2.31 | 504.5 | 10.6 | 4,225.5 | 15.4 | 18.8 |
| Dabur India | 383.55 | 34.3 | 68,128 | 2.15 | 586.2 | 15.0 | 3,764.4 | 10.6 | 20.3 |
| Colgate-Palmoliv | 1,757.40 | 35.0 | 47,918 | 2.73 | 343.1 | 7.8 | 1,603.3 | 11.8 | 108.0 |
| Cupid | 343.95 | 336.7 | 46,264 | 0.00 | 44.2 | 194.0 | 157.0 | 142.5 | 33.9 |
| Gillette India | 7,223.50 | 35.2 | 23,521 | 2.49 | 159.5 | 9.4 | 783.0 | 10.8 | 90.7 |
| P & G Hygiene | 6,921.00 | 28.4 | 22,469 | 3.32 | 126.3 | -34.3 | 891.5 | -4.9 | 157.2 |
| Emami | 375.45 | 21.8 | 16,479 | 2.66 | 138.9 | -16.4 | 1,039.2 | 14.9 | 28.1 |
| Bajaj Consumer | 483.00 | 28.3 | 6,308 | 0.00 | 70.8 | 84.8 | 341.6 | 24.9 | 30.1 |
| Median | 454.55 | 38.2 | 16,019 | 0.34 | 90.5 | 15.0 | 756.0 | 15.4 | 30.2 |
Competes with: Colgate-Palmolive India, Cupid Limited, Dabur India, Emami Limited, Gillette India Limited, Godrej Consumer Products, Procter & Gamble Hygiene and Health Care Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 270 | 235 | 239 | 240 | 246 | 234 | 234 | 250 | 273 | 265 | 306 | 327 | 342 |
| Expenses | 222 | 198 | 203 | 205 | 209 | 201 | 208 | 219 | 232 | 217 | 250 | 250 | 258 |
| Material Cost | 77 | 91 | 74 | 84 | 81 | 48 | |||||||
| Change in Inventories | 3.32 | 2.95 | -5.10 | -0.97 | 1.90 | 7.73 | |||||||
| Purchases of Stock-in-Trade | 33 | 19 | 37 | 39 | 36 | 75 | |||||||
| Employee Cost | 29 | 35 | 35 | 36 | 36 | 36 | |||||||
| Other Expenses | 76 | 78 | 77 | 92 | 96 | 92 | |||||||
| Operating Profit | 48 | 37 | 36 | 35 | 37 | 33 | 26 | 32 | 41 | 48 | 56 | 77 | 83 |
| OPM % | 18 | 16 | 15 | 14 | 15 | 14 | 11 | 13 | 15 | 18 | 18 | 23 | 24 |
| Other Income | 11 | 11 | 11 | 12 | 11 | 9 | 8 | 9 | 8 | 8 | 5 | 6 | 8 |
| Exceptional items (within Other Income) | 0.48 | 0.29 | 0 | 0 | 0 | 0 | |||||||
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 4 | 5 | 5 | 4 |
| Profit before tax | 56 | 45 | 44 | 44 | 45 | 39 | 31 | 38 | 46 | 51 | 56 | 78 | 87 |
| Tax % | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 18 | 17 | 18 | 18 | 18 | 19 |
| Net Profit | 46 | 37 | 36 | 36 | 37 | 32 | 25 | 31 | 38 | 42 | 46 | 64 | 71 |
| EPS in Rs | 3.24 | 2.61 | 2.55 | 2.49 | 2.60 | 2.32 | 1.85 | 2.26 | 2.79 | 3.24 | 3.55 | 4.87 | 5.42 |
| Diluted EPS in Rs | 2.23 | 2.77 | 3.09 | 3.44 | 4.75 | 5.42 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 817 | 800 | 797 | 828 | 918 | 852 | 922 | 880 | 961 | 984 | 965 | 1,165 | 1,240 |
| Expenses | 578 | 526 | 533 | 575 | 644 | 647 | 678 | 706 | 820 | 829 | 837 | 944 | 976 |
| Material Cost | 267 | 330 | |||||||||||
| Change in Inventories | 0.52 | -1.21 | |||||||||||
| Purchases of Stock-in-Trade | 174 | 130 | |||||||||||
| Employee Cost | 112 | 141 | |||||||||||
| Other Expenses | 284 | 343 | |||||||||||
| Operating Profit | 239 | 274 | 264 | 254 | 274 | 205 | 243 | 174 | 141 | 155 | 128 | 221 | 264 |
| OPM % | 29 | 34 | 33 | 31 | 30 | 24 | 26 | 20 | 15 | 16 | 13 | 19 | 21 |
| Other Income | -15 | -18 | 21 | 24 | 17 | 30 | 35 | 39 | 37 | 45 | 36 | 27 | 27 |
| Exceptional items (within Other Income) | 0.48 | 0.29 | |||||||||||
| Interest | 0 | 0 | 1 | 1 | 1 | 4 | 1 | 1 | 1 | 1 | 1 | 1.61 | 2 |
| Depreciation | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 5 | 9 | 10 | 10 | 15 | 17 |
| Profit before tax | 219 | 250 | 278 | 270 | 283 | 225 | 270 | 206 | 169 | 189 | 153 | 231 | 273 |
| Tax % | 21 | 22 | 22 | 22 | 22 | 18 | 17 | 18 | 18 | 18 | 18 | 18 | |
| Net Profit | 173 | 196 | 218 | 211 | 222 | 185 | 223 | 170 | 139 | 155 | 125 | 190 | 223 |
| EPS in Rs | 12 | 13 | 15 | 14 | 15 | 13 | 15 | 12 | 9.63 | 11 | 9.14 | 15 | 17 |
| Diluted EPS in Rs | 9.03 | 14 | |||||||||||
| Dividend Payout % | 98 | 86 | 78 | 84 | 93 | 16 | 66 | 70 | 51 | 28 | 0 | 0 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 4%
- 5 years
- 5%
- 3 years
- 7%
- TTM
- 25%
Compounded profit growth
- 10 years
- -2%
- 5 years
- -4%
- 3 years
- 10%
- TTM
- 76%
Stock price CAGR
- 10 years
- 2%
- 5 years
- 14%
- 3 years
- 28%
- 1 year
- 100%
Return on equity
- 10 years
- 27%
- 5 years
- 20%
- 3 years
- 20%
- Last year
- 25%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 13 |
| Reserves | 474 | 466 | 479 | 478 | 453 | 638 | 742 | 795 | 775 | 816 | 734 | 742 |
| Borrowings | 0 | 10 | 15 | 13 | 25 | 20 | 5 | 0 | 9 | 9 | 4 | 16 |
| Other Liabilities | 79 | 75 | 80 | 102 | 113 | 141 | 132 | 122 | 125 | 144 | 149 | 174 |
| Minority Interest | 0 | 0 | ||||||||||
| Total Liabilities | 568 | 566 | 590 | 608 | 605 | 815 | 894 | 931 | 924 | 984 | 901 | 945 |
| Fixed Assets | 185 | 139 | 162 | 158 | 154 | 151 | 149 | 152 | 160 | 158 | 154 | 298 |
| CWIP | 1 | 1 | 0 | 15 | 22 | 27 | 25 | 28 | 28 | 28 | 28 | 27 |
| Investments | 184 | 275 | 339 | 307 | 251 | 446 | 585 | 612 | 575 | 586 | 401 | 367 |
| Other Assets | 199 | 151 | 90 | 127 | 178 | 191 | 135 | 140 | 161 | 212 | 318 | 253 |
| Total Assets | 568 | 566 | 590 | 608 | 605 | 815 | 894 | 931 | 924 | 984 | 901 | 945 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 207 | 193 | 212 | 180 | 176 | 179 | 237 | 129 | 101 | 116 | 65 | 197 |
| Cash from Investing Activity | -19 | 6 | -15 | 37 | 68 | -173 | -106 | 0 | 64 | 12 | 155 | -15 |
| Cash from Financing Activity | -204 | -194 | -200 | -216 | -238 | -9 | -134 | -124 | -163 | -120 | -212 | -196 |
| Net Cash Flow | -16 | 5 | -3 | 1 | 6 | -3 | -3 | 5 | 2 | 9 | 8 | -14 |
| Free Cash Flow | 206 | 176 | 177 | 162 | 167 | 173 | 235 | 118 | 95 | 112 | 59 | 164 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 12 | 13 | 14 | 15 | 11 | 9 | 8 | 12 | 16 | 27 | 24 |
| Inventory Days | 72 | 61 | 58 | 63 | 73 | 84 | 48 | 57 | 43 | 46 | 45 | 52 |
| Days Payable | 95 | 53 | 55 | 92 | 87 | 108 | 76 | 45 | 37 | 33 | 41 | 34 |
| Cash Conversion Cycle | -16 | 20 | 16 | -15 | 1 | -13 | -20 | 19 | 17 | 30 | 31 | 42 |
| Working Capital Days | -7 | -2 | -9 | -1 | 9 | 5 | -6 | 1 | 5 | 7 | 21 | 9 |
| ROCE % | 52 | 60 | 57 | 53 | 58 | 39 | 38 | 26 | 21 | 23 | 19 | 30 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
-390inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-09-30
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-09-30
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-09-30
FY revenue / permanent employees + workers, same basis (calc)
2,29,44,779inr
2026-03-31
News
News and filings about Bajaj Consumer Care Limited. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- Aloe vera extract
- Liquid Light Paraffin (LLP) / mineral oil
- PET bottles
- PP caps
- Perfume / fragrance inputs
- Refined vegetable oils (almond, mustard/sarson, coconut)
- Vitamin E
Depends on the price of
- Crude Oil Brent
Buys from
- Gandhar Oil Refinery (India) Limited · White oils / mineral oil for hair-oil & personal care
- Haldyn Glass Limited · glass bottles for hair oil / personal care
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Personal Care
- Classification
- Fast Moving Consumer Goods › Personal Care
- ISIN
- INE933K01021
Plants
- Bajaj Consumer Care - Guwahati plant
- Bajaj Consumer Care - Paonta Sahib plant
News impact
Big market events that reach Bajaj Consumer Care Limited, and how the effect spreads.
19 Jun, 04:22 IST · Market event · medium impact
Marico cuts Parachute coconut oil price by 17% as copra costs fall; jasmine hair oil hiked
Who it hits first
- MARICO: Marico itself: Parachute price cut -17% on copra cost relief. Net positive: margin expansion potential. PE 60.5 >> FMCG median 25.7 (premium); ROE 43.0 >> 11.4.
- DABUR: DABUR Vatika hair oil benefits from copra deflation. PE 39.7 above FMCG median 25.7; ROE 17.2 above 11.4.
Who may gain
- DABUR: DABUR Vatika hair oil benefits from copra deflation. PE 39.7 above FMCG median 25.7; ROE 17.2 above 11.4.
- BAJAJCON: Bajaj Consumer Almond Drops is highest coconut-oil exposure. PE 31.1 above FMCG median 25.7; ROE 25.3 above 11.4; D/E 0.02 — strong.
- EMAMILTD: Emami Kesh King and Navratna oils benefit. PE 25.0 at FMCG median 25.7; ROE 30.2 above 11.4.
Along the supply chain
Downstream
Coconut oil hair-care retailers, kirana stores benefit from lower-priced Parachute SKU mix; consumer trade-up to premium variants potential.
Upstream
Kerala/Tamil Nadu copra farmers face price pressure; coconut oil mills see margin squeeze. Marico is largest copra buyer in India — sets cost benchmark.
Where demand moves
Business
Marico cuts Parachute price 17% on copra cost relief → competitive pricing pressure on DABUR Vatika, BAJAJCON Almond Drops, EMAMILTD Navratna. Demand-side: lower MRP boosts volume growth across coconut-oil category for FY27.
Capital
Modest rotation into FMCG hair oil names — copra cycle turn improves FY27 gross margin visibility 200-400 bps for category leaders.
How it spreads across sectors
Agriculture
Coconut farmer price weakness — negative for Kerala rural economy
FMCG
Copra deflation positive for hair oil margin cycle
Commodity angle
Cc skip reason
Copra not tracked in commodity prices table; pricing action by Marico itself indicates ~15-20% cost relief based on Parachute 17% price cut
Commodity
Copra
Shock type
price_deflation
When it plays out
Immediate
BAJAJCON, DABUR see 1-3% positive on margin expectations; MARICO mixed (volume vs ASP trade-off).
Medium term
Copra cycle bottom may extend into FY27H2 — sustained margin tailwind for coconut-oil exposed FMCG.
Short term
Q1FY27 (Jul earnings) will reflect copra deflation in gross margin print.
18 Apr, 04:10 IST · Market event · medium impact
Bajaj Consumer Care Q4 Profit Doubles to ₹63 cr — Stock +16%
Who it hits first
- BAJAJCON +16% intraday on profit beat
Who may gain
- Mid-cap FMCG re-rating: Emami, Marico potential follow-through
Along the supply chain
Downstream
Distribution chain
Upstream
Packaging, oils suppliers
Where demand moves
Business
No demand shift
Capital
Money rotates into mid-cap FMCG
How it spreads across sectors
FMCG
Bajaj Consumer turnaround narrative validates mid-cap re-rating thesis
When it plays out
Immediate
Stock +16% Friday
Medium term
Sustained if margin expansion continues in Q1FY27
Short term
Analyst target hikes likely
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 16 Feb 2024 | interim | ₹3 |
|---|---|---|
| 2 Aug 2023 | unspecified | ₹5 |
| 22 Jul 2022 | unspecified | ₹4 |
| 10 Feb 2022 | interim | ₹4 |
| 11 Jun 2021 | unspecified | ₹4 |
| 11 Feb 2021 | interim | ₹6 |
| 11 Sep 2020 | unspecified | ₹2 |
| 18 Jan 2019 | interim | ₹14 |
Splits, bonuses & buybacks
- daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016
Bulk & block deals
| Date | Who | Bought / sold | Shares | Price |
|---|---|---|---|---|
| 17 Apr 2026 | MICROCURVES TRADING PRIVATE LIMITED | SELL | 10,26,395 | ₹473.59 |
| 17 Apr 2026 | MICROCURVES TRADING PRIVATE LIMITED | BUY | 10,26,377 | ₹473.45 |
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Earnings call13 Jul 2026
- Annual report · 2025-2611 Jul 2026
- Results presentation30 Jun 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.